Daniel G. Maluf MD FACS, FAST, (He/Him)
[Pronunciation: Professor of Surgery and Medicine, University of Maryland]
Transplantation
Professor, Surgery, University of Maryland School of Medicine
Join to View Full Profile
29 S Greene StBaltimore, MD 21201
Phone+1 410-328-5941
Fax+1 410-328-5941
Dr. Maluf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Maluf is a general surgeon specializing in transplantation, based in Baltimore, MD. He graduated from the University of Virginia School of Medicine in 1998. Dr. Maluf currently serves as the Director of the Program in Transplantation at the University of Maryland Medical Center since 2020. He has previous experience as a faculty member at Virginia Commonwealth University. His expertise includes hepatic cirrhosis and transplant surgery. Dr. Maluf has contributed several publications to the field, including research on living liver donation, liver transplantation governance, and liver graft protection. He is also involved in clinical trials such as developing strategies to prevent hepatitis C recurrence post-liver transplantation. Dr. Maluf has been recognized for his work with CMS Meaningful Use certifications from Epic Systems Corporation.
Education & Training
University of Virginia School of MedicineClass of 1998
Certifications & Licensure
MD State Medical License 2020 - 2027
NJ State Medical License 2026 - 2027
VA State Medical License 2001 - 2026
TN State Medical License 2018 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy Start of enrollment: 2006 Jan 01
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Reprogramming Hepatic Resilience: BMK1 as a Cytoprotective Axis in Liver Ischemia-reperfusion Injury.Daniel G Maluf, David Al-Adra, Valeria R Mas
Transplantation. 2026-04-21 - Strategic leadership and financial governance in liver transplantation: Global insights from the International Liver Transplantation Society Congress 2025.Aghnia J Putri, Zoltan Czigany, Alfred W C Kow, Daniel G Maluf, Markus Selzner
Liver Transplantation. 2026-04-01 - Donor-derived cell-free DNA in combination with liver function tests for biopsy decision-making in pediatric liver transplantation.Guido Trezeguet Renatti, Agostina Arrigone, Catalina Costas, Julia Minetto, Andrea Bosaleh
Liver Transplantation. 2026-03-02
Press Mentions
New Advanced Procedure at the University of Maryland Medical Center Results in Lifesaving Liver TransplantOctober 1st, 2024
Grant Support
- Assessment of Donor Quality for Improving Kidney Transplant OutcomesNIH2004–2028
Committees
- CoChair, Business Excecutive Committee International Liver Transplant Society 2023 - Present
Other Languages
- Spanish, Italian
External Links
- Pubmed https://pubmed.ncbi.nlm.nih.gov/?term=Maluf+D%2C+&sort=date
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
